Logo

Stratagene, Rosetta Inpharmatics to Co-Develop RNA Purification System

Aug 14, 2006

NEW YORK (GenomeWeb News) – Stratagene said today that it has formed a joint development and license agreement with Rosetta Inpharmatics to create automated solution for the isolation of nucleic acids from clinical samples.

Under the deal, the companies will jointly develop an instrument and a single-use consumable, which will be manufactured Stratagene for sale to its customers engaged in pharmacogenomics.

Additional terms of the agreement were not disclosed.

Breaking News
The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.